🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
The Anatomy of a Biologics Warning Letter: Deconstructing Genzyme Waterford’s FDA Audit ◆ The Dublin-Backed Roll-Up Reshaping UK Pharma Packaging: Inside Woodberry's Double Acquisition ◆ The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected ◆ Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots ◆ A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ The Anatomy of a Biologics Warning Letter: Deconstructing Genzyme Waterford’s FDA Audit ◆ The Dublin-Backed Roll-Up Reshaping UK Pharma Packaging: Inside Woodberry's Double Acquisition ◆ The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected ◆ Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots ◆ A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 08 Jul 2026 · ClinicalTrials.gov

Clinical Trials in Connecticut

← All US trials

The most recently updated industry-sponsored clinical trials recruiting across the United States — searchable by condition, sponsor, phase and state. Refreshed daily from the ClinicalTrials.gov registry.

31
Recruiting now
41
Studies tracked
Connecticut
Selected state
Active Phase 1/Phase 2
GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors
Malignant Solid Tumor, Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Melanoma
Genmab · started 2019-09-17
📍 Alaska · California · Connecticut · Delaware · Florida · Illinois · Kentucky · Maryland
NCT04083599 on ClinicalTrials.gov ↗
Recruiting
MagnetOs Flex Matrix Compared to Trinity Elite Mixed With Local Autograft in Patients Undergoing up to Four-level Instrumented Posterolateral Fusion
Degenerative Disc Disease, Spine Fusion, Leg Pain and/or Back Pain
Kuros Biosurgery AG · started 2024-06-10
📍 Connecticut · Illinois · Maryland · Michigan · North Carolina · Ohio · Utah · Virginia
NCT05037968 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma
Janssen Research & Development, LLC · started 2013-09-09
📍 California · Connecticut · Georgia · Illinois · Indiana · Kansas · Kentucky · Massachusetts
NCT01804686 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Alzheimers Disease
Hoffmann-La Roche · started 2025-11-12
📍 Arizona · California · Connecticut · Florida · Georgia · Illinois · Massachusetts · Michigan
NCT07170150 on ClinicalTrials.gov ↗
Recruiting Phase 2
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations
Solid Tumours
Boehringer Ingelheim · started 2024-10-11
📍 Alaska · Arizona · California · Connecticut · Florida · Illinois · Indiana · Maryland
NCT06581432 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Eli Lilly and Company · started 2025-10-15
📍 Alabama · Arizona · Arkansas · California · Colorado · Connecticut · Florida · Georgia
NCT07165028 on ClinicalTrials.gov ↗
Active Phase 3
Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer
Platinum-resistant Ovarian Cancer
Genmab · started 2025-02-07
📍 Alaska · Arizona · California · Colorado · Connecticut · Florida · Georgia · Hawaii
NCT06619236 on ClinicalTrials.gov ↗
Recruiting Phase 3
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Heart Failure, Heart Failure With Reduced Ejection Fraction
Cytokinetics · started 2024-12-19
📍 Alabama · Arizona · California · Colorado · Connecticut · Florida · Georgia · Hawaii
NCT06736574 on ClinicalTrials.gov ↗
Recruiting Phase 3
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Carcinoma, Non-Small-Cell Lung
Eli Lilly and Company · started 2025-03-27
📍 Alabama · Arizona · Arkansas · California · Connecticut · District of Columbia · Florida · Georgia
NCT06890598 on ClinicalTrials.gov ↗
Recruiting Phase 1
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
Solid Malignancies, Hematologic Malignancies
Immunome, Inc. · started 2025-02-26
📍 California · Colorado · Connecticut · Georgia · Iowa · Kentucky · Michigan · Nebraska
NCT06823167 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis
Eli Lilly and Company · started 2025-12-12
📍 Alabama · Arizona · Arkansas · California · Colorado · Connecticut · District of Columbia · Florida
NCT07218380 on ClinicalTrials.gov ↗
Starting soon Phase 3
Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer
Platinum-Sensitive Ovarian Cancer, Ovarian Cancer
Genmab · started 2026-07
📍 Connecticut · Wisconsin
NCT07564141 on ClinicalTrials.gov ↗
Active Phase 2
A Study of JSB462 (Luxdegalutamide) Plus Lutetium (177Lu) Vipivotide Tetraxetan in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
Prostatic Cancer, Castration-Resistant
Novartis Pharmaceuticals · started 2025-07-03
📍 California · Colorado · Connecticut · Indiana · Massachusetts · Nebraska · New York · Pennsylvania
NCT07047118 on ClinicalTrials.gov ↗
Recruiting Phase 2
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe
Eli Lilly and Company · started 2026-03-26
📍 Arizona · California · Colorado · Connecticut · Florida · Idaho · Illinois · Indiana
NCT07415044 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Alzheimer Disease
Karuna Therapeutics, Inc., a Bristol Myers Squibb company · started 2024-09-26
📍 Arizona · California · Connecticut · Florida · Georgia · Massachusetts · Michigan · Mississippi
NCT06585787 on ClinicalTrials.gov ↗
Active Phase 2
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Janssen Research & Development, LLC · started 2022-09-19
📍 California · Colorado · Connecticut · District of Columbia · Florida · Georgia · Idaho · Indiana
NCT05242484 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Hoffmann-La Roche · started 2025-10-24
📍 Alaska · Arizona · California · Colorado · Connecticut · Florida · Georgia · Idaho
NCT06793215 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Study of Brenipatide in Adult Participants With Schizophrenia
Schizophrenia
Eli Lilly and Company · started 2026-02-10
📍 Arkansas · California · Connecticut · Florida · Georgia · Illinois · Maryland · Massachusetts
NCT07410507 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Ovarian Neoplasms, Fallopian Tube Neoplasms, Peritoneal Neoplasms, Neoplasm Metastasis
Eli Lilly and Company · started 2025-10-22
📍 Alabama · Arizona · California · Colorado · Connecticut · Florida · Georgia · Hawaii
NCT07213804 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
Multiple Myeloma
AbbVie · started 2025-07-23
📍 California · Connecticut · Massachusetts · Michigan · New York · North Carolina · Oregon · Texas
NCT06953960 on ClinicalTrials.gov ↗
Recruiting Phase 3
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Pancreatic Cancer, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Ductal Adenocarcinoma (PDAC)
Revolution Medicines, Inc. · started 2025-12-15
📍 California · Colorado · Connecticut · Florida · Georgia · Indiana · Kansas · Maryland
NCT07252232 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Obesity, Overweight
Eli Lilly and Company · started 2026-02-06
📍 Alabama · Arizona · California · Connecticut · Florida · Georgia · Hawaii · Iowa
NCT07321886 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Endometrial Cancer
Merck Sharp & Dohme LLC · started 2025-05-22
📍 Alabama · Alaska · California · Connecticut · District of Columbia · Florida · Georgia · Illinois
NCT06952504 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC
Adenocarcinoma, Pancreatic Ductal
Genentech, Inc. · started 2023-10-18
📍 California · Connecticut · Illinois · Indiana · Kentucky · Massachusetts · Michigan · Nebraska
NCT05968326 on ClinicalTrials.gov ↗
Recruiting Phase 3
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Alzheimers Disease
Hoffmann-La Roche · started 2025-07-02
📍 Alabama · Arizona · California · Connecticut · Florida · Georgia · Hawaii · Illinois
NCT07177352 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
Diabetic Peripheral Neuropathic Pain
Eli Lilly and Company · started 2026-02-16
📍 Alabama · Arizona · California · Connecticut · Florida · Georgia · Illinois · Louisiana
NCT07285018 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
Depressive Disorder, Major
Eli Lilly and Company · started 2026-02-09
📍 California · Connecticut · Florida · Georgia · Indiana · Iowa · Maryland · Massachusetts
NCT07412756 on ClinicalTrials.gov ↗
Recruiting Phase 2
INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
Type 1 Diabetes Mellitus
Mannkind Corporation · started 2026-02-04
📍 California · Colorado · Connecticut · Florida · Indiana · Massachusetts · Oklahoma · Texas
NCT07224321 on ClinicalTrials.gov ↗
Active Phase 3
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation
Heart Failure
Novo Nordisk A/S · started 2023-05-08
📍 Alabama · Arizona · Arkansas · California · Colorado · Connecticut · Florida · Georgia
NCT05636176 on ClinicalTrials.gov ↗
Active Phase 2
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma
Non-Hodgkin Lymphoma
Genmab · started 2022-06-14
📍 Arizona · Connecticut · Delaware · Florida · Georgia · Maryland · Missouri · New York
NCT05283720 on ClinicalTrials.gov ↗
Recruiting Phase 3
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric Patients
Irritability Associated With Autism Spectrum Disorder
Intra-Cellular Therapies, Inc. · started 2024-12-06
📍 Arkansas · California · Connecticut · Florida · Georgia · Illinois · Indiana · Louisiana
NCT06706674 on ClinicalTrials.gov ↗
Recruiting Phase 1
Trial to Evaluate the Safety and Preliminary Efficacy of GEN1079 in Participants With Advanced Solid Tumors
Advanced Solid Tumors
Genmab · started 2026-04-07
📍 Connecticut · Michigan · New York
NCT07387068 on ClinicalTrials.gov ↗
Active Phase 3
ABTECT - Maintenance
Ulcerative Colitis
Abivax S.A. · started 2023-01-16
📍 Alabama · Arizona · Arkansas · California · Colorado · Connecticut · Florida · Georgia
NCT05535946 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
Osteoarthritis
Eli Lilly and Company · started 2025-09-15
📍 Arizona · California · Colorado · Connecticut · Georgia · Illinois · Kansas · Massachusetts
NCT07153471 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Overweight, Obesity
Eli Lilly and Company · started 2025-12-15
📍 Alabama · Arizona · California · Colorado · Connecticut · Florida · Georgia · Hawaii
NCT07282600 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Overweight, Obesity
Eli Lilly and Company · started 2026-02-10
📍 Alabama · Arizona · California · Connecticut · Florida · Georgia · Idaho · Illinois
NCT07392190 on ClinicalTrials.gov ↗
Active Phase 2
A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Hidradenitis Suppurativa
Eli Lilly and Company · started 2023-10-23
📍 Arizona · Arkansas · California · Connecticut · Florida · Georgia · Illinois · Indiana
NCT06046729 on ClinicalTrials.gov ↗
Active Phase 2
A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes
Type 2 Diabetes Mellitus
Hoffmann-La Roche · started 2025-08-19
📍 Arizona · California · Connecticut · District of Columbia · Florida · Georgia · Illinois · Montana
NCT07112872 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis
Eli Lilly and Company · started 2023-12-21
📍 Alabama · Arizona · Arkansas · California · Colorado · Connecticut · District of Columbia · Florida
NCT06119581 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Obesity, Overweight
Eli Lilly and Company · started 2023-11-17
📍 Arizona · California · Connecticut · Florida · Hawaii · Idaho · Illinois · Iowa
NCT06143956 on ClinicalTrials.gov ↗
Recruiting
Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body
Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion
Bayer · started 2020-04-03
📍 Arizona · California · Colorado · Connecticut · Florida · Indiana · Kansas · Maine
NCT04142437 on ClinicalTrials.gov ↗
No trials match your search.

Browse by state

California · 125 Florida · 104 Georgia · 66 Illinois · 58 Arizona · 57 Colorado · 55 Connecticut · 41 Michigan · 38 Indiana · 37 Alabama · 37 Massachusetts · 36 Texas · 35 New York · 32 Maryland · 27 Ohio · 24 Arkansas · 22

Browse by condition

Obesity · 7 Overweight · 6 Advanced Solid Tumors · 5 Neoplasm Metastasis · 4 Colitis, Ulcerative · 4 Melanoma · 3 Non-small Cell Lung Cancer · 3 Alzheimer Disease · 3 Crohn Disease · 3 Schizophrenia · 3 Small Lymphocytic Lymphoma · 2 Follicular Lymphoma · 2 Osteoarthritis · 2 Overweight or Obesity · 2 Alzheimers Disease · 2 Diabetes Mellitus, Type 1 · 2
Cite this page

Priya Life Science (2026). Clinical Trials in the USA Tracker. Available at: https://priyalifescience.com/clinical-trials-usa/state/connecticut (Accessed: 8 July 2026).

Source: ClinicalTrials.gov, U.S. National Library of Medicine — industry-sponsored studies in a recruiting status with at least one US site, most recently updated first, refreshed daily. This is a curated slice of the full registry, not every US trial. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. Compare pay for the teams running these studies in our US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish and EU sites, see our Ireland and EU trackers.